Yondelis® (ET-743, Trabectedin) sensitizes cancer cell lines to CD95-mediated cell death: new molecular insight into the mechanism of action.

Source:http://linkedlifedata.com/resource/pubmed/id/21371453

Eur. J. Pharmacol. 2011 May 11 658 2-3 57-64

Download in:

View as

General Info

PMID
21371453